|
|
||||||||
,
,1



,



,

AstraZeneca R&D, Mölndal, Sweden; and
Wallenberg Laboratory for Cardiovascular Research, Göteborg University, Sweden
1Correspondence: Department of Integrative Pharmacology, AstraZeneca R&D, S-431 83 Mölndal, Sweden. E-mail: daniel.linden{at}astrazeneca.com
Glycerol-3-phosphate acyltransferase (GPAT) catalyzes the first committed step in triacylglycerol (TAG) and phospholipid biosynthesis. GPAT activity has been identified in both ER and mitochondrial subcellular fractions. The ER activity dominates in most tissues except in liver, where the mitochondrial isoform (mtGPAT) can constitute up to 50% of the total activity. To study the in vivo effects of hepatic mtGPAT overexpression, mice were transduced with adenoviruses expressing either murine mtGPAT or a catalytically inactive variant of the enzyme. Overexpressing mtGPAT resulted in massive 12- and 7-fold accumulation of liver TAG and diacylglycerol, respectively but had no effect on phospholipid or cholesterol ester content. Histological analysis showed extensive lipid accumulation in hepatocytes. Furthermore, mtGPAT transduction markedly increased adipocyte differentiation-related protein and stearoyl-CoA desaturase-1 (SCD-1) in the liver. In line with increased SCD-1 expression, 18:1 and 16:1 in the hepatic TAG fraction increased. In addition, mtGPAT overexpression decreased ex vivo fatty acid oxidation, increased liver TAG secretion rate 2-fold, and increased plasma TAG and cholesterol levels. These results support the hypothesis that increased hepatic mtGPAT activity associated with obesity and insulin resistance contributes to increased TAG biosynthesis and inhibition of fatty acid oxidation, responses that would promote hepatic steatosis and dyslipidemia.Lindén, D., William-Olsson, L., Ahnmark, A., Ekroos, K., Hallberg, C., Sjögren, H. P., Becker, B., Svensson, L., Clapham, J. C., Oscarsson, J., Schreyer, S. Liver-directed overexpression of mitochondrial glycerol-3-phosphate acyltransferase results in hepatic steatosis, increased triacylglycerol secretion and reduced fatty acid oxidation.
Key Words: GPAT stearoyl-CoA desaturase ADRP adenovirus fatty liver
This article has been cited by other articles:
![]() |
R. E. Gimeno and J. Cao Thematic Review Series: Glycerolipids. Mammalian glycerol-3-phosphate acyltransferases: new genes for an old activity J. Lipid Res., October 1, 2008; 49(10): 2079 - 2088. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Hou, H. Zhou, F. Elisma, S. A. L. Bennett, and D. Figeys Technological developments in lipidomics Brief Funct Genomic Proteomic, September 19, 2008; (2008) eln042v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Horikawa, T. Nomura, T. Hashimoto, and K. Sakamoto Elongation and Desaturation of Fatty Acids are Critical in Growth, Lipid Metabolism and Ontogeny of Caenorhabditis elegans J. Biochem., August 1, 2008; 144(2): 149 - 158. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Q. Chen, M.-S. Kuo, S. Li, H. H. Bui, D. A. Peake, P. E. Sanders, S. J. Thibodeaux, S. Chu, Y.-W. Qian, Y. Zhao, et al. AGPAT6 Is a Novel Microsomal Glycerol-3-phosphate Acyltransferase J. Biol. Chem., April 11, 2008; 283(15): 10048 - 10057. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Lelliott, A. Ljungberg, A. Ahnmark, L. William-Olsson, K. Ekroos, A. Elmgren, G. Arnerup, C. C. Shoulders, J. Oscarsson, and D. Linden Hepatic PGC-1 Overexpression Induces Combined Hyperlipidemia and Modulates the Response to PPAR{alpha} Activation Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2707 - 2713. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. W. Mitchell, K. Ekroos, S. J. Blanksby, A. J. Hulbert, and P. L. Else Differences in membrane acyl phospholipid composition between an endothermic mammal and an ectothermic reptile are not limited to any phospholipid class J. Exp. Biol., October 1, 2007; 210(19): 3440 - 3450. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Huang, C. Yang, Y. Luo, C. Jin, F. Wang, and W. L. McKeehan FGFR4 Prevents Hyperlipidemia and Insulin Resistance but Underlies High-Fat Diet Induced Fatty Liver Diabetes, October 1, 2007; 56(10): 2501 - 2510. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Nagle, J. An, M. Shiota, T. P. Torres, G. W. Cline, Z.-X. Liu, S. Wang, R. L. Catlin, G. I. Shulman, C. B. Newgard, et al. Hepatic Overexpression of Glycerol-sn-3-phosphate Acyltransferase 1 in Rats Causes Insulin Resistance J. Biol. Chem., May 18, 2007; 282(20): 14807 - 14815. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Gonzalez-Baro, T. M. Lewin, and R. A. Coleman Regulation of Triglyceride Metabolism II. Function of mitochondrial GPAT1 in the regulation of triacylglycerol biosynthesis and insulin action Am J Physiol Gastrointest Liver Physiol, May 1, 2007; 292(5): G1195 - G1199. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Parkes, E. Preston, D. Wilks, M. Ballesteros, L. Carpenter, L. Wood, E. W. Kraegen, S. M. Furler, and G. J. Cooney Overexpression of acyl-CoA synthetase-1 increases lipid deposition in hepatic (HepG2) cells and rodent liver in vivo Am J Physiol Endocrinol Metab, October 1, 2006; 291(4): E737 - E744. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |